The annual Centre for Research Excellence into Injecting Drug Use (CREIDU) Colloquium will coincide with International Overdose Awareness Day. Reflecting on this important day, the focus will be on take-home naloxone, a key response to opioid overdose in Australia. With an interactive format and an exciting mix of speakers, the Colloquium draws together researchers and practitioners to present on local and interstate developments around take-home naloxone.
Join us at the Eliminate Hep C Symposium hosted by collaborating partner Burnet Institute.
Burnet Institute is proud to host the annual Colloquium for the Centre for Research Excellence into Injecting Drug Use (CREIDU) focusing on prisons and injecting drug use.
CREIDU is hosting its second Research Update for 2015. CREIDU Research Updates are designed to present findings from current research into injecting drug use and critically analyse their implications for practice.
CREIDU is hosting a Research Update on the topic of Hepatitis C, which is designed to assist workers in the community sector to keep up to date with current research in injecting drug use and critically analyse implications for practice.
Do you want to learn to evaluate your programs and services more effectively? Find out how to tell your story to contribute to quality improvement and organisational sustainability and future growth, whilst satisfying funding body expectations and requirements effectively.
CAHMA, WASUA, Harm Reduction Vic and QUIHN have combined to put together a three part workshop showcasing peer-based naloxone and overdose prevention training specifically for drug and alcohol workers.
AIDS 2014 panel discussion to explore the notion of treatment as prevention among people who inject drugs.
Hosted by Burnet Institute, the annual Colloquium for the Centre for Research Excellence into Injecting Drug Use (CREIDU) will focus on ‘treatment as prevention’ – using treatment as a method of preventing the spread and harms of HIV and hepatitis C in people who inject drugs.
A seminar co-sponsored by CREIDU and the Centre for Mental Health, University of Melbourne
Advancing the Agenda is the fourth national conference run for and by women living with HIV (WLWHIV) in Australia
This seminar will bring together a diverse range of speakers and panelists who will highlight some of the issues facing women living with and affected by chronic HIV and/or viral hepatitis, with an emphasis on the implications for service delivery and improving health outcomes.
Do you want to promote your service and the good work it does? It is time for NSP workers and their services to take centre stage. Anex are looking for photos of NSP heroes engaging in what they do best, providing good support to their clients.
A health promotion project raising awareness about viral hepatitis transmission amongst young people
Hepatitis Victoria presents a workshop designed for anyone working with people who are at risk of or affected by hepatitis C. The session covers an introduction to hepatitis C, diagnosis and treatment (including a personal perspective), the impact and meaning of hepatitis C for people who inject drugs and case studies.
The National Drug Trends Conference will present recent findings in illicit drug use, markets and related harms across Australia and internationally. Convened by Australia’s largest drug monitoring systems, the Illicit Drug Reporting System (IDRS) and the Ecstasy and Related Drugs Reporting System (EDRS), the one day conference will include the first release of the 2013 findings.
CREIDU's Proessor Paul Dietze will give an update on naloxone distribution programs in Australia.
Associate Professor Jane Buxton, harm reduction lead at the British Columbia Centre for Disease Control in Canada, will talk about the naloxone program in BC and the overdose monitoring systems that are in place.
The interactive forum will provide an opportunity for AOD stakeholders in the western metropolitan region to get together and discuss regional issues, and how to best respond together. A number of key experts and organisations will participate in discussions, including CREIDU's Dr Mark Stoové who will present on reducing AOD harms for those within the justice system.
Injecting-related harms is the focus of a one-day Colloquium in Melbourne hosted by the Centre for Research Excellence into Injecting Drug Use (CREIDU).
Presented by experts at the National Drug Research Institute and other international opinion leaders, this one-week intensive unit aims to provide a framework to improve integration of research into drug policy formulation at local, state, national and international levels.
Treatment as prevention is the single most important strategy presently available to interrupt the chain of transmission for many blood-bourne viruses.The day will include presentations by Kirby academics and invited international and national guests, on a range of work related to treatment as prevention.
Hepatitis Victoria and Harm Reduction Victoria present a workshop designed for anyone working with people who are at risk of or affected by hepatitis C. The session covers the facts, impact for those who inject drugs, diagnosis and treatment.
Come along to hear about new research in alcohol and other drug policy and participate in discussions about policy issues.
This forum aims to explore various perspectives and to generate informed discussion on an appropriate approach to Naloxone service provision in Victoria. Presentations from a range of experts will cover related policy, research, program delivery, consumer and family perspectives and trauma informed interventions.
Come along to the official community launch of the North Richmond Public Injecting Impact Study by Robyn Dwyer, Robert Power and Paul Dietze.
This symposium will explore current policy and clinical responses to injecting drug use and infectious disease in prisoners and ex- prisoners, both in Australia and internationally. It will explore how these policies and practices impact on health, in the context of available evidence.
The Centre for Research Excellence into Injecting Drug Use (CREIDU) is proud to host a one-day colloquium which will look at what’s new in hepatitis C and injecting drug use with a focus on prevention, treatment and care.
Professor Frederick Altice of Yale School of Medicine will speak about his work in treating blood borne viruses amongst people who inject drugs in custodial settings.
International Overdose Awareness Day is held on August 31st each year. Commemorating those who have met with death or permanent injury as a result of drug overdose, it also acknowledges the grief felt by their families and friends. Celebrated around the world, International Overdose Awareness Day aims to raise awareness of overdose and eradicate the stigma attached to it.
With an interactive format and exciting mix of speakers this Colloquium is designed to draw together researchers, affected community members, policy makers and practitioners to discuss the latest research findings related to addiction treatment and the implications for policy and practice.
The Centre for Research Excellence into Injecting Drug Use (CREIDU) inaugural annual Colloquium is designed to draw together researchers, affected community members, policy makers and practitioners to discuss research findings and the implications for policy and practice. With an interactive format and exciting mix of Australian and international speakers our first Colloquium promises to be a memorable and high quality event.